ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Net Income 2013–2025
ImmunityBio, Inc. annual/quarterly net income history and growth rate from 2013 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- ImmunityBio, Inc. net income for the quarter ending March 31, 2026 was -632.8 M, a 388.08% increase year-over-year.
- ImmunityBio, Inc. net income for the twelve months ending March 31, 2026 was -922.2 M, a 104.95% increase year-over-year.
- ImmunityBio, Inc. annual net income for 2025 was -351.4 M, a 15.03% decrease from 2024.
- ImmunityBio, Inc. annual net income for 2024 was -413.6 M, a 29.09% decrease from 2023.
- ImmunityBio, Inc. annual net income for 2023 was -583.2 M, a 40.00% increase from 2022.
- ImmunityBio, Inc. annual net income for 2022 was -416.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ImmunityBio, Inc. Net Income — FAQ
ImmunityBio, Inc. (IBRX) net income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is ImmunityBio, Inc.'s net income?
ImmunityBio, Inc. (IBRX) reported net income of -$351M for fiscal 2025.
Where can I see IBRX's net income history?
The chart and table above show ImmunityBio, Inc.'s net income by year and by quarter, including the growth rate.